Abridge
Ambient AI platform for clinical documentation with provenance and clinician review workflows.
Last updated: June 8, 2026
Back to directoryClinical documentation product from SmarterDx/Smarter Technologies that generates notes from patient-record context and embeds CDI, coding, and reimbursement intelligence.
Health systems evaluating inpatient documentation automation where note quality, physician query reduction, CDI review, coding completeness, and revenue integrity are governed together.
Compare within workflow: Clinical documentation and scribes · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating SmarterNotes as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat SmarterNotes as medium-risk documentation, CDI, coding, and revenue-integrity support rather than autonomous diagnosis; classify any patient-specific prompt, diagnosis-completeness suggestion, quality metric, or reimbursement recommendation separately. |
|---|---|
| Privacy | Do not rely only on public website privacy language for PHI terms because SmarterDx says enterprise customer data may be governed by customer agreements; review BAA, EHR permissions, retention, support access, audit logs, subprocessors, and data-use restrictions. |
| Evidence | Pilot with representative inpatient services and measure unsupported note content, omitted facts, CDI/coding suggestion accuracy, physician query volume, discharge-summary timing, edit burden, denial outcomes, and compliance audit findings. |
| Workflow | Best governed as clinician-reviewed inpatient note drafting with explicit handoffs among physicians, CDI, coders, quality, revenue integrity, privacy, and AI governance teams before outputs affect signed notes or claims. |
SmarterDx describes SmarterNotes as a note-generation workflow that uses patient history, labs, medications, vitals, flowsheets, clinical AI, and documentation nudges; Smarter Technologies states that SmarterNotes combines SmarterDx clinical AI with Pieces documentation workflows after acquiring Pieces Technologies, while the Texas Attorney General settlement over Pieces-era healthcare genAI accuracy claims makes accuracy disclosure, human reliance limits, and hallucination monitoring essential diligence items.
Not for: Unsigned autonomous documentation, diagnosis capture without clinician and coding review, outpatient-only ambient transcription assumptions, or deployment without hallucination, PHI, BAA, and enterprise-contract review.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.